Emil Pharmaceutical Industries is a finished-dose manufacturer based in India. It appears in 111 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), FDA (GH) and MINSA (CR). Its GMP standing is certified by EMA and NAFDAC (NG). Customs aggregates show $18.0M of exports covering 698 molecules to 16 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Boisar, United Arab Emirates | Not on file |
| Boisar, India | Not on file |
| Palghar, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 46 | None |
| FDA (GH) | 41 | None |
| MINSA (CR) | 15 | None |
| ARCSA (EC) | 5 | None |
| DIGEMAPS (DO) | 2 | None |
| JFDA (JO) | 1 | None |
| EMA | None | 1 |
| NAFDAC (NG) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $3.1M | 9 |
| 2025 | Not reported | $18.0M | 16 |
| 2024 | Not reported | $18.0M | 15 |
| 2023 | Not reported | $12.2M | 11 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Emil Pharmaceutical Industries comes back tiered against every other supplier able to file there.
Start for free